Lipocine Inc reports results for the quarter ended September 30 - Earnings Summary

Lipocine Inc reported a quarterly adjusted loss of 59 cents per share for the quarter ended September 30, compared to a loss of 41 cents in the same quarter last year. Revenue was $115,000, below the expected $238,000. The company incurred a quarterly loss of $3.19 million, and shares fell by 10.2% this quarter. Analysts maintain a "buy" rating, with a median 12-month price target of $7.38, representing a potential upside of 65.3% from the last closing price of $2.56.